Oncology Molecular Imaging, LLC (OMI) was formed in early 2005 as a leading edge onsite provider of Positron Emission Tomography (“PET”) and Computer Tomography (“CT”) imaging services to small and mid-sized oncology groups throughout the US. OMI’s imaging program offers oncology practices and, in certain situations, healthcare imaging facilities such as hospitals or independent imaging centers a complete solution that enhances patient services while enabling clients to capture revenues that would otherwise have been lost to third-party imaging providers. Currently, OMI operates nine onsite imaging centers.

Scroll to top